<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Johnson & Johnson Services, Inc.

    Johnson & Johnson Services, Inc.

    Johnson & Johnson engages in the research and development, manufacture, and sale o...

    Johnson & Johnson engages in the research and d...

    Filing Type:    PU
    Mesoblast Limited

    Mesoblast Limited

    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a world leader in developing allogene...

    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a ...

    Filing Type:    PU
    Robovet Corporation

    Robovet Corporation

    Robovet Corporation has developed a new MR imaging technology that can also help t...

    Robovet Corporation has developed a new MR imag...

    Amount Raised:    $136,889.00
    Fundraising Status:    EC
    Filing Type:    CF
    T2 Biosystems, Inc.

    T2 Biosystems, Inc.

    T2 Biosystems, a leader in the development and commercialization of innovative med...

    T2 Biosystems, a leader in the development and ...

    Filing Type:    PU
    Hancock Jaffe Laboratories, Inc.

    Hancock Jaffe Laboratories, Inc.

    HJLI specializes in developing and manufacturing bioprosthetic medical devices to ...

    HJLI specializes in developing and manufacturin...

    Filing Type:    PU
    Viemed Healthcare, Inc.

    Viemed Healthcare, Inc.

    Viemed Healthcare Inc is a high level service provider using best in class technol...

    Viemed Healthcare Inc is a high level service p...

    Filing Type:    PU
    AxoGen, Inc.

    AxoGen, Inc.

    Axogen (AXGN) is a global leader in innovative surgical solutions for peripheral n...

    Axogen (AXGN) is a global leader in innovative ...

    Filing Type:    PU
    Smilelove LLC

    Smilelove LLC

    Smilelove offers clear aligner treatments direct-to-consumer: no expensive appoint...

    Smilelove offers clear aligner treatments direc...

    Amount Raised:    $704,405.00
    Fundraising Status:    SD
    Filing Type:    CF
    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology (“GCT”) is an emerging medical technology company with nu...

    Global Cancer Technology (“GCT”) is an emerging...

    Amount Raised:    $82,711.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.